American Heart Association: Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

November 17, 2024
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death

https://newsroom.heart.org/news/exenatide-a-glp-1-analog-by-iv-during-cardiac-surgery-did-not-reduce-organ-injury-or-death

---

Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe